Novo Nordisk has appointed Jamey Millar, former CEO of Optum Specialty Holdings, as the drug company’s executive vice president of U.S. operations, effective Feb. 5. In the role, Mr. Millar will oversee Novo Nordisk’s largest sales region, according to Novo…
Author: Paige Twenter
UnitedHealth Group’s Optum Rx is monitoring three notable drug candidates that might be approved in the next few months, according to its winter 2026 report published Jan. 2. Two of the medications Optum Rx is tracking are also on GoodRx’s…
Here's how the six largest health insurance companies and their pharmacy benefit manager companies stack up.
